MAR Research Update — May 7, 2026
Updated Thesis
Marriott International operates a global fee-driven, asset-light hotel business with a portfolio of over 30 brands and a strong competitive position in the travel lodging industry. The company benefits from a durable competitive moat supported by its brand strength, extensive network, and recurring franchise and management fees. However, recent financials show significant headwinds with a 71.1% year-over-year revenue decline in the most recent quarter and negative 2.6% earnings growth, reflecting ongoing challenges in travel demand normalization and government-related disruptions.
The investment grade as of this refresh is D — solid business quality. Medium-tier business, high-tier valuation with 69.5% downside to $109.69 fair value
Key Metrics at a Glance
- Revenue growth: -71.1% year over year
- Net margin: 11.9%
- Forward P/E: 37.7x
- Fair value upside: -69.5% to our estimate of $110
Current price: $359.06
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Marriott International, Inc. remains in our covered universe with a solid-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full MAR research →](/stocks/MAR)